BrainStorm Cell Therapeutics Inc. , a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the ...

Investor call and webcast scheduled for today at 8:30 a.m. ET NEW YORK, May 19, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading ...

Researchers led by Maike Sander, scientific director of the Max Delbrück Center, have developed a vascularized organoid model ...

The thyroid is a small, butterfly-shaped gland located in the neck. Despite its size, it has a profound effect on the body’s ...

Biomedical engineers at Georgia Tech created a treatment that could one day unlock a universal strategy for treating some of ...

Nearly half of sequencing data labeled as endometriosis lacks true disease representation, highlighting the urgent need for more diverse and accurate tissue sampling to advance research in this ...

Led by University of Michigan researchers, a study in Cancer Cell identified a new target for Group-3 medulloblastomas. The results help identify new therapeutic avenues for treating these deadly ...

When mice implanted with metastasis-prone human cancer cells were treated with compounds that targeted ACBP’s activity, none ...

Focus on potential partnership and strategic opportunities for the Company’s stem cell therapy program for Alzheimer’s disease Recent Type B meeting with FDA provided alignment on a planned single, ...

CRISPR-edited iPSCs uncover early mitochondrial defects shared across ALS mutations, revealing pathways that could guide future treatments.

Research teams have created a versatile set of gene delivery systems that can reach different neural cell types in the human brain and spinal cord with exceptional accuracy. These delivery systems are ...

This work developed a method to determine and experimentally validate design spaces for mesenchymal stem cell cultivation using mathematical modeling and simulation. Liver organoids derived from ...